Choo Z, Koh X, Wong M, Ashokan R, Ali Ahamed N, Kang C
Cancer Res Commun. 2023; 3(11):2386-2399.
PMID: 37874199
PMC: 10681007.
DOI: 10.1158/2767-9764.CRC-23-0082.
Mukherjee A, Bravo-Cordero J
Cancer Metastasis Rev. 2023; 42(1):99-112.
PMID: 36802311
PMC: 10027413.
DOI: 10.1007/s10555-023-10094-2.
de Vasconcelos Gaspar A, Branco M, Galhano E, Ramos F
Radiol Case Rep. 2022; 17(12):4914-4919.
PMID: 36281281
PMC: 9586847.
DOI: 10.1016/j.radcr.2022.09.066.
Zeineldin M, Patel A, Dyer M
Neuron. 2022; 110(18):2916-2928.
PMID: 35985323
PMC: 9509448.
DOI: 10.1016/j.neuron.2022.07.012.
Pfister S, Reyes-Mugica M, Chan J, Hasle H, Lazar A, Rossi S
Cancer Discov. 2021; 12(2):331-355.
PMID: 34921008
PMC: 9401511.
DOI: 10.1158/2159-8290.CD-21-1094.
Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.
Zhang A, Aslam H, Sharma N, Warmflash A, Fakhouri W
Cells Tissues Organs. 2021; 210(3):151-172.
PMID: 34218225
PMC: 8387394.
DOI: 10.1159/000516466.
Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
Dou X, Tong P, Huang H, Zellmer L, He Y, Jia Q
J Cancer. 2020; 11(10):2887-2920.
PMID: 32226506
PMC: 7086263.
DOI: 10.7150/jca.41324.
WNT Signaling in Neuroblastoma.
Becker J, Wilting J
Cancers (Basel). 2019; 11(7).
PMID: 31331081
PMC: 6679057.
DOI: 10.3390/cancers11071013.
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
Vivancos Stalin L, Gualandi M, Schulte J, Renella R, Shakhova O, Muhlethaler-Mottet A
Front Oncol. 2019; 9:275.
PMID: 31058082
PMC: 6477091.
DOI: 10.3389/fonc.2019.00275.
Neuroblastoma-A Neural Crest Derived Embryonal Malignancy.
Johnsen J, Dyberg C, Wickstrom M
Front Mol Neurosci. 2019; 12:9.
PMID: 30760980
PMC: 6361784.
DOI: 10.3389/fnmol.2019.00009.
Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.
Ogorodnikov A, Levin M, Tattikota S, Tokalov S, Hoque M, Scherzinger D
Nat Commun. 2018; 9(1):5331.
PMID: 30552333
PMC: 6294251.
DOI: 10.1038/s41467-018-07580-5.
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko I, Kalinovsky D, Doronin I, Deyev S, Kholodenko R
J Immunol Res. 2018; 2018:7394268.
PMID: 30116755
PMC: 6079467.
DOI: 10.1155/2018/7394268.
A causal mechanism for childhood acute lymphoblastic leukaemia.
Greaves M
Nat Rev Cancer. 2018; 18(8):471-484.
PMID: 29784935
PMC: 6986894.
DOI: 10.1038/s41568-018-0015-6.
Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma.
Hultman I, Haeggblom L, Rognmo I, Edqvist J, Blomberg E, Ali R
PLoS One. 2018; 13(1):e0190970.
PMID: 29342186
PMC: 5771584.
DOI: 10.1371/journal.pone.0190970.
Spontaneous regression of neuroblastoma.
Brodeur G
Cell Tissue Res. 2018; 372(2):277-286.
PMID: 29305654
PMC: 5920563.
DOI: 10.1007/s00441-017-2761-2.
WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.
Becker J, Wilting J
Cell Mol Life Sci. 2017; 75(6):1057-1070.
PMID: 29058015
PMC: 5814469.
DOI: 10.1007/s00018-017-2685-8.
The MYCN Protein in Health and Disease.
Ruiz-Perez M, Henley A, Arsenian-Henriksson M
Genes (Basel). 2017; 8(4).
PMID: 28358317
PMC: 5406860.
DOI: 10.3390/genes8040113.
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.
Carter D, Sutton S, Pajic M, Murray J, Sekyere E, Fletcher J
Mol Oncol. 2016; 10(6):866-78.
PMID: 26996379
PMC: 5423163.
DOI: 10.1016/j.molonc.2016.02.004.
Disseminated Congenital Neuroblastoma - An Autopsy Case Report.
Wader J, Kumbhar S, Shukla D, Mavi S
J Clin Diagn Res. 2015; 9(5):ED03-4.
PMID: 26155483
PMC: 4484075.
DOI: 10.7860/JCDR/2015/13163.5922.
Mechanisms of neuroblastoma regression.
Brodeur G, Bagatell R
Nat Rev Clin Oncol. 2014; 11(12):704-13.
PMID: 25331179
PMC: 4244231.
DOI: 10.1038/nrclinonc.2014.168.
